A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Phase 3
Not yet recruiting
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- Behavioral: Psychological Support
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 330
- Registration Number
- NCT06793397
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 468
- Registration Number
- NCT06605105
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Phase 3
Recruiting
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 220
- Registration Number
- NCT06564818
- Locations
- πΊπΈ
Noble Clinical Research, Tucson, Arizona, United States
πΊπΈCenExel CIT (Clinical Innovations, Inc), Bellflower, California, United States
πΊπΈKadima Neuropsychiatry Institute, La Jolla, California, United States
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants with Generalized Anxiety Disorder (GAD)
Phase 2
Recruiting
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Behavioral: Psychotherapy
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 36
- Registration Number
- NCT06051721
- Locations
- πΊπΈ
Innovative Clinical Research, Inc., Miami Lakes, Florida, United States
πΊπΈCedar Clinical Research, Murray, Utah, United States
πΊπΈCenExel ACMR, Atlanta, Georgia, United States
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder
Phase 1
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2022-05-23
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 57
- Registration Number
- NCT05385783
- Locations
- πΊπΈ
CenExel ACMR, Atlanta, Georgia, United States
πΊπΈClinilabs Drug Development Corporation, Eatontown, New Jersey, United States
πΊπΈiResearch Atlanta, Decatur, Georgia, United States
Β© Copyright 2025. All Rights Reserved by MedPath